Delivery Order SPE2DB20D3101-SPE2DB24FRFW9
Award Date 4/9/24
Potential Completion Date 4/10/24
Potential Value $1.5K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,102.22 firm fixed-price delivery order is for the supply of LINZESS 145 MCG CAPSULE medical products, with a period of performance through November 4, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,451.78 fixed-price delivery order is for the supply of LINZESS 290 MCG capsules to support military healthcare programs. The contract has an ultimate completion date of March 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,280.72 firm fixed-price contract is for the delivery of LINZESS 145 MCG CAPSULE UU 30S, a prescription medication. The contract has an ultimate completion date of June 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award is for the delivery of LINZESS 72 MCG CAPSULE UU 30S, a pharmaceutical product, with a ceiling value of $1,047.73 and a completion date of March 13, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of LINZESS 72 MCG capsules, a prescription medication. The award is a firm fixed-price Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999, which enables DLA to efficiently procure a comprehensive range of medical commodities from AmerisourceBergen to support...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide LINZESS 290 MCG CAPSULE UU 30S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price of $1,484.48. The ultimate completion date is July 29, 2024. This appears to be a contract under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025 that Amerisourcebergen holds with the DLA Troop...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA) for the delivery of LINZESS 145 MCG capsules. The $11,706.10 firm fixed price delivery order contract has a completion date of June 10, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,849.83, is a Firm Fixed Price Delivery Order for the supply of LINZESS 290 MCG Capsules to support military healthcare programs. The contract has an ultimate completion date of July 1, 2024 and was awarded on June 28, 2024. This contract award is part of a larger Indefinite Delivery Contract...
- This federal contract award, valued at $4,101.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for LINZESS 145 MCG Capsules, an essential pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of LINZESS 145MCG 30S, a prescription medication. The $13,833.32 fixed-price contract has an ultimate completion date of July 2, 2025 and was awarded on June 4, 2025 by the Defense Logistics Agency (DLA), a defense agency that provides supplies and services to the U.S. military. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...